[HTML][HTML] Role for anti-cytokine therapies in severe coronavirus disease 2019

LF Buckley, GF Wohlford, C Ting… - Critical care …, 2020 - journals.lww.com
Objectives: The causative agent for coronavirus disease 2019, severe acute respiratory
syndrome coronavirus 2, appears exceptional in its virulence and immunopathology. In …

[HTML][HTML] Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019

LF Buckley, GF Wohlford, C Ting… - Critical Care …, 2020 - ncbi.nlm.nih.gov
Objectives: The causative agent for coronavirus disease 2019, severe acute respiratory
syndrome coronavirus 2, appears exceptional in its virulence and immunopathology. In …

Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019

LF Buckley, GF Wohlford, C Ting… - Critical care …, 2020 - pubmed.ncbi.nlm.nih.gov
The causative agent for coronavirus disease 2019, severe acute respiratory syndrome
coronavirus 2, appears exceptional in its virulence and immunopathology. In some patients …

Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019.

LF Buckley, GF Wohlford, C Ting, A Alahmed… - Critical Care …, 2020 - europepmc.org
Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …

[引用][C] Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019

LF Buckley, GF Wohlford, C Ting, A Alahmed… - Critical Care …, 2020 - cir.nii.ac.jp

[HTML][HTML] Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019

LF Buckley, GF Wohlford, C Ting… - Critical Care …, 2020 - journals.lww.com
Objectives: The causative agent for coronavirus disease 2019, severe acute respiratory
syndrome coronavirus 2, appears exceptional in its virulence and immunopathology. In …